• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症 COVID-19 痊愈数月后出现新型 SARS-CoV-2 检测阳性:再感染还是间歇性病毒脱落?

A new positive SARS-CoV-2 test months after severe COVID-19 illness: reinfection or intermittent viral shedding?

机构信息

Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, Connecticut, USA

Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, Connecticut, USA.

出版信息

BMJ Case Rep. 2021 Feb 4;14(2):e240531. doi: 10.1136/bcr-2020-240531.

DOI:10.1136/bcr-2020-240531
PMID:33542020
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8098910/
Abstract

We present a case of a patient who had a history of severe coronavirus disease (COVID-19) 4 months prior to this current presentation and, after a long asymptomatic period, subsequently tested positive for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) by a RNA PCR assay, after several interval negative SARS-CoV-2 RNA tests. We present this potential case of SARS-CoV-2 reinfection in order to incite discussion around differentiating persistent infection with intermittent viral shedding and reinfection, as well as to discuss evolving knowledge and approaches to the clinical management, follow-up molecular testing and treatment of COVID-19 reinfection.

摘要

我们报告了 1 例病例,该患者在此次就诊前 4 个月患有严重的冠状病毒病(COVID-19),在长时间无症状期后,多次间隔性 SARS-CoV-2 RNA 检测阴性后,通过 RNA PCR 检测呈严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)阳性。我们提出了这种潜在的 SARS-CoV-2 再感染的情况,目的是引发关于持续感染伴间歇性病毒脱落与再感染的区别的讨论,并讨论关于 COVID-19 再感染的临床管理、随访分子检测和治疗的不断发展的知识和方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b80f/8098910/e6b7a32b4ec5/bcr-2020-240531f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b80f/8098910/e6b7a32b4ec5/bcr-2020-240531f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b80f/8098910/e6b7a32b4ec5/bcr-2020-240531f01.jpg

相似文献

1
A new positive SARS-CoV-2 test months after severe COVID-19 illness: reinfection or intermittent viral shedding?重症 COVID-19 痊愈数月后出现新型 SARS-CoV-2 检测阳性:再感染还是间歇性病毒脱落?
BMJ Case Rep. 2021 Feb 4;14(2):e240531. doi: 10.1136/bcr-2020-240531.
2
Respiratory Viral Shedding in Healthcare Workers Reinfected with SARS-CoV-2, Brazil, 2020.巴西 2020 年医护人员再感染 SARS-CoV-2 的呼吸道病毒脱落情况。
Emerg Infect Dis. 2021;27(6):1737-1740. doi: 10.3201/eid2706.210558. Epub 2021 Apr 19.
3
Viral Shedding among Re-Positive Severe Acute Respiratory Syndrome Coronavirus-2 Positive Individuals in Republic of Korea.韩国再次检测出新型冠状病毒呈阳性个体的病毒脱落情况。
Viruses. 2021 Oct 17;13(10):2089. doi: 10.3390/v13102089.
4
Predictors of severe symptomatic laboratory-confirmed SARS-CoV-2 reinfection.预测严重有症状的实验室确诊 SARS-CoV-2 再感染的因素。
Public Health. 2021 Apr;193:113-115. doi: 10.1016/j.puhe.2021.01.021. Epub 2021 Feb 12.
5
Clinical characteristics and potential factors for recurrence of positive SARS-CoV-2 RNA in convalescent patients: a retrospective cohort study.恢复期患者 SARS-CoV-2 RNA 复阳的临床特征及潜在影响因素:一项回顾性队列研究。
Clin Exp Med. 2021 Aug;21(3):361-367. doi: 10.1007/s10238-021-00687-y. Epub 2021 Feb 4.
6
A Patient with Asymptomatic SARS-CoV-2 Infection Who Presented 86 Days Later with COVID-19 Pneumonia Possibly Due to Reinfection with SARS-CoV-2.一名无症状的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染者,86天后出现可能因再次感染SARS-CoV-2导致的新型冠状病毒肺炎(COVID-19)。
Am J Case Rep. 2020 Dec 1;21:e927154. doi: 10.12659/AJCR.927154.
7
Differentials of SARS-CoV-2 Viral RNA Re-positivity in Discharged COVID-19 Patients.出院新冠患者中 SARS-CoV-2 病毒 RNA 再阳性的差异。
AIDS Rev. 2021 Jun 3;23(3):153-163. doi: 10.24875/AIDSRev.21000023.
8
Retest positive for SARS-CoV-2 RNA of "recovered" patients with COVID-19: Persistence, sampling issues, or re-infection?新冠肺炎“康复”患者的 SARS-CoV-2 RNA 复测阳性:持续性、采样问题还是再感染?
J Med Virol. 2020 Nov;92(11):2263-2265. doi: 10.1002/jmv.26114. Epub 2020 Jun 9.
9
SARS-CoV-2 reinfection.严重急性呼吸综合征冠状病毒2型再次感染
Med Intensiva (Engl Ed). 2021 Aug-Sep;45(6):375-376. doi: 10.1016/j.medine.2021.04.009. Epub 2021 May 2.
10
Reinfection with two genetically distinct SARS-CoV-2 viruses within 19 days.在19天内再次感染两种基因不同的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒。
J Med Virol. 2021 Oct;93(10):5700-5703. doi: 10.1002/jmv.27154. Epub 2021 Jul 5.

引用本文的文献

1
Role of COVID-19 infection status on the prediction of future infection: Immunity or susceptibility.新冠病毒感染状态对未来感染预测的作用:免疫还是易感性。
PLoS One. 2025 Mar 26;20(3):e0317959. doi: 10.1371/journal.pone.0317959. eCollection 2025.
2
COVID-19 Reinfection Rate and Related Risk Factors in Fars Province, Iran: A Retrospective Cohort Study.伊朗法尔斯省 COVID-19 再感染率及相关危险因素:一项回顾性队列研究。
Iran J Med Sci. 2023 May;48(3):302-312. doi: 10.30476/IJMS.2022.94615.2598.
3
Clinical and epidemiological features of patients with COVID-19 reinfection: a systematic review.

本文引用的文献

1
Clinical characteristics of recovered COVID-19 patients with re-detectable positive RNA test.新冠病毒核酸检测复阳康复患者的临床特征
Ann Transl Med. 2020 Sep;8(17):1084. doi: 10.21037/atm-20-5602.
2
A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity.冠状病毒抗体介导免疫的系统评价:动力学、保护相关性及与严重程度的关系。
Nat Commun. 2020 Sep 17;11(1):4704. doi: 10.1038/s41467-020-18450-4.
3
Clinical, immunological and virological characterization of COVID-19 patients that test re-positive for SARS-CoV-2 by RT-PCR.
新冠病毒二次感染患者的临床和流行病学特征:一项系统综述
New Microbes New Infect. 2022 Jul;48:101021. doi: 10.1016/j.nmni.2022.101021. Epub 2022 Aug 28.
4
Influenza A, Influenza B, and SARS-CoV-2 Similarities and Differences - A Focus on Diagnosis.甲型流感、乙型流感和新型冠状病毒2019(SARS-CoV-2)的异同——聚焦诊断
Front Microbiol. 2022 Jun 20;13:908525. doi: 10.3389/fmicb.2022.908525. eCollection 2022.
5
Decision making - Should we perform kidney transplantation on a patient with a positive RT-PCR test for SARS-CoV-2?决策制定——对于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)逆转录聚合酶链反应(RT-PCR)检测呈阳性的患者,我们应该为其进行肾移植吗?
Nefrologia. 2022 May 27. doi: 10.1016/j.nefro.2022.04.007.
6
Clinical manifestations, treatment options, and comorbidities in COVID-19 relapse patients: A systematic review.COVID-19 复发患者的临床表现、治疗选择和合并症:系统评价。
J Clin Lab Anal. 2022 May;36(5):e24402. doi: 10.1002/jcla.24402. Epub 2022 Apr 8.
7
SARS-CoV-2 Reinfection Is a New Challenge for the Effectiveness of Global Vaccination Campaign: A Systematic Review of Cases Reported in Literature.SARS-CoV-2 再次感染对全球疫苗接种运动的效果构成新挑战:对文献报告病例的系统评价。
Int J Environ Res Public Health. 2021 Oct 19;18(20):11001. doi: 10.3390/ijerph182011001.
8
DTC genetic test for customized cosmetics in COVID-19 pandemic: Focused on women in their 40s and 60s in Seoul, Republic of Korea.DTC 基因检测在新冠疫情期间定制化妆品:聚焦韩国首尔 40 多岁和 60 多岁的女性。
J Cosmet Dermatol. 2021 Oct;20(10):3085-3092. doi: 10.1111/jocd.14377. Epub 2021 Oct 10.
9
A look into the future of the COVID-19 pandemic in Europe: an expert consultation.欧洲新冠疫情的未来展望:一次专家咨询
Lancet Reg Health Eur. 2021 Sep;8:100185. doi: 10.1016/j.lanepe.2021.100185. Epub 2021 Jul 30.
10
Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients Undergoing Serial Laboratory Testing.对连续进行实验室检测的患者中严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)再感染的研究。
Clin Infect Dis. 2022 Jan 29;74(2):294-300. doi: 10.1093/cid/ciab345.
经 RT-PCR 检测 SARS-CoV-2 再次呈阳性的 COVID-19 患者的临床、免疫学和病毒学特征。
EBioMedicine. 2020 Sep;59:102960. doi: 10.1016/j.ebiom.2020.102960. Epub 2020 Aug 24.
4
Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing.2019 年冠状病毒病(COVID-19)通过全基因组测序确认为与严重急性呼吸综合征冠状病毒 2 株系不同的病毒再次感染。
Clin Infect Dis. 2021 Nov 2;73(9):e2946-e2951. doi: 10.1093/cid/ciaa1275.
5
SARS-CoV-2: The viral shedding vs infectivity dilemma.严重急性呼吸综合征冠状病毒2:病毒脱落与传染性的困境。
Infect Dis Health. 2020 Aug;25(3):210-215. doi: 10.1016/j.idh.2020.05.002. Epub 2020 May 20.
6
The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection.体液免疫反应在感染 SARS-CoV-2 后的动态变化和再次感染的可能性。
J Gen Virol. 2020 Aug;101(8):791-797. doi: 10.1099/jgv.0.001439.
7
Antibody responses to SARS-CoV-2 in patients with COVID-19.新型冠状病毒肺炎(COVID-19)患者的 SARS-CoV-2 抗体反应。
Nat Med. 2020 Jun;26(6):845-848. doi: 10.1038/s41591-020-0897-1. Epub 2020 Apr 29.
8
Temporal dynamics in viral shedding and transmissibility of COVID-19.新冠病毒脱落和传播的时间动态。
Nat Med. 2020 May;26(5):672-675. doi: 10.1038/s41591-020-0869-5. Epub 2020 Apr 15.
9
Virological assessment of hospitalized patients with COVID-2019.住院 COVID-19 患者的病毒学评估。
Nature. 2020 May;581(7809):465-469. doi: 10.1038/s41586-020-2196-x. Epub 2020 Apr 1.
10
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019.新型冠状病毒病 2019 患者的 SARS-CoV-2 抗体反应。
Clin Infect Dis. 2020 Nov 19;71(16):2027-2034. doi: 10.1093/cid/ciaa344.